These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7193534)

  • 21. Acute and chronic cisplatin nephropathy in rats.
    Choie DD; Longnecker DS; del Campo AA
    Lab Invest; 1981 May; 44(5):397-402. PubMed ID: 7194946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of effect of metoclopramide on cisplatin-induced nephrotoxicity in rats.
    Buyan RD; Schroeder RL; Perkins WE
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):135-8. PubMed ID: 4081306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis.
    Schade RR; Dugas MC; Lhotsky DM; Gavaler JS; Van Thiel DH
    Dig Dis Sci; 1985 Jan; 30(1):10-5. PubMed ID: 3965270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metoclopramide therapy in fifty-five patients with delayed gastric emptying.
    Perkel MS; Hersh T; Moore C; Davidson ED
    Am J Gastroenterol; 1980 Sep; 74(3):231-6. PubMed ID: 7468558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metoclopramide-induced normalization of impaired gastric emptying in spinal cord injury.
    Segal JL; Milne N; Brunnemann SR; Lyons KP
    Am J Gastroenterol; 1987 Nov; 82(11):1143-8. PubMed ID: 3673993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of hydrolysis products of aqua(1,1-bis(aminomethyl)cyclohexane)sulfatoplatinum(II) on toxicity in rats.
    Elferink F; Van der Vijgh WJ; Van der Poort SE; Henzen-Logmans SC; Pinedo HM
    Cancer Lett; 1984 Nov; 25(1):61-9. PubMed ID: 6542826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin combined with prostaglandin E1 chemotherapy in rat peritoneal carcinomatosis.
    Ikeguchi M; Maeta M; Kaibara N
    Int J Cancer; 2000 Nov; 88(3):474-8. PubMed ID: 11054679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal function and renal platinum content in uninephrectomized rats following cisplatin administration.
    Natochin YV; Reznik LV; Bakchteeva VT; Lavrova EA
    Ren Fail; 1993; 15(2):157-62. PubMed ID: 8469782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of a new gastrointestinal drug--metoclopramide.
    Ponte CD; Nappi JM
    Am J Hosp Pharm; 1981 Jun; 38(6):829-33. PubMed ID: 7018232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis.
    Erbas T; Varoglu E; Erbas B; Tastekin G; Akalin S
    Diabetes Care; 1993 Nov; 16(11):1511-4. PubMed ID: 8299441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoid suppression by cis-platinum(II) amines. What are the active agents?
    Fairlie DP; Whitehouse MW
    Biochem Pharmacol; 1982 Mar; 31(6):933-9. PubMed ID: 7200774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue platinum concentrations and cisplatin schedules.
    Cavaletti G; Tredici G; Pizzini G; Minoia A
    Lancet; 1990 Oct; 336(8721):1003. PubMed ID: 1976980
    [No Abstract]   [Full Text] [Related]  

  • 33. [Toxic effect of cisplatin and certain platinum complexes of the 2d generation (CHIP, oxoplatina) on the gastrointestinal tract in rats].
    Filipová M; Srámek B; Kvĕtina J
    Bratisl Lek Listy; 1986 Jan; 85(1):49-53. PubMed ID: 3955396
    [No Abstract]   [Full Text] [Related]  

  • 34. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics.
    McCallum RW; Valenzuela G; Polepalle S; Spyker D
    J Pharmacol Exp Ther; 1991 Jul; 258(1):136-42. PubMed ID: 2072291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of verapamil on cis-platinum and carboplatinum nephrotoxicity in dehydrated and normohydrated rats.
    Haragsim L; Zima T
    Biochem Int; 1992 Oct; 28(2):273-6. PubMed ID: 1360799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacology of intraperitoneal cisplatin.
    Lopez JA; Krikorian JG; Reich SD; Smyth RD; Lee FH; Issell BF
    Gynecol Oncol; 1985 Jan; 20(1):1-9. PubMed ID: 4038390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low renal toxicity of lipoplatin compared to cisplatin in animals.
    Devarajan P; Tarabishi R; Mishra J; Ma Q; Kourvetaris A; Vougiouka M; Boulikas T
    Anticancer Res; 2004; 24(4):2193-200. PubMed ID: 15330160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison in rodents of renal and intestinal toxicity of cisplatin and a new water-soluble antitumor platinum complex: N-methyl-iminodiacetato-diaminocyclohexane platinum (II).
    Newman RA; Khokhar AR; Sunderland BA; Travis EL; Bulger RE
    Toxicol Appl Pharmacol; 1986 Jul; 84(3):454-63. PubMed ID: 3726868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Structure-activity relations of antineoplastic platinum II and platinum IV coordination compounds].
    Gutsche W; Baumgart J; Schröer HP
    Arch Geschwulstforsch; 1989; 59(4):233-8. PubMed ID: 2802931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.